Photosensitizer‐Amplified Antimicrobial Materials for Broad‐Spectrum Ablation of Resistant Pathogens in Ocular Infections
Advanced Materials · 2024-08 · 36 (31)
DOI: 10.1002/adma.202404107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 27.05.2024. Verfasst von Charles Lochenie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, University of Edinburgh, 4-5 Little France Drive, Edinburgh, EH16 4UU, UK. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CARB-X, Ministry of Education, Singapore, Horizon 2020.
Abstract (Originalsprache)
The emergence of multidrug resistant (MDR) pathogens and the scarcity of new potent antibiotics and antifungals are one of the biggest threats to human health. Antimicrobial photodynamic therapy (aPDT) combines light and photosensitizers to kill drug‐resistant pathogens; however, there are limited materials that can effectively ablate different classes of infective pathogens. In the present work, a new class of benzodiazole‐paired materials is designed as highly potent PDT agents with broad‐spectrum antimicrobial activity upon illumination with nontoxic light. The results mechanistically demonstrate that the energy transfer and electron transfer between nonphotosensitive and photosensitive benzodiazole moieties embedded within pathogen‐binding peptide sequences result in increased singlet oxygen generation and enhanced phototoxicity. Chemical optimization renders PEP3 as a novel PDT agent with remarkable activity against MDR bacteria and fungi as well as pathogens at different stages of development (e.g., biofilms, spores, and fungal hyphae), which also prove effective in an ex vivo porcine model of microbial keratitis. The chemical modularity of this strategy and its general compatibility with peptide‐based targeting agents will accelerate the design of highly photosensitive materials for antimicrobial PDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Inflammation Research, University of Edinburgh, 4-5 Little France Drive, Edinburgh, EH16 4UU, UK.
- IRR Chemistry Hub, Institute for Regeneration and Repair, 4-5 Little France Drive, Edinburgh, EH16 4UU, UK.
- Fluorescence Research Group, Singapore University of Technology and Design, 8 Somapah Road, Singapore, 487372, Singapore.
ORCID-Profile: Marc Vendrell
Förderung
- CARB-X
- Ministry of Education, Singapore
- Horizon 2020
- Engineering and Physical Sciences Research Council
- UK Research and Innovation
- European Research Council
Zitieren
APA
Lochenie, C., Duncan, S., Zhou, Y., Fingerhut, L., Kiang, A., Benson, S., Jiang, G., Liu, X., Mills, B., & Vendrell, M. (2024). Photosensitizer‐Amplified Antimicrobial Materials for Broad‐Spectrum Ablation of Resistant Pathogens in Ocular Infections. Advanced Materials, 36(31). https://doi.org/10.1002/adma.202404107
Vancouver
Lochenie C, Duncan S, Zhou Y, Fingerhut L, Kiang A, Benson S, et al. Photosensitizer‐Amplified Antimicrobial Materials for Broad‐Spectrum Ablation of Resistant Pathogens in Ocular Infections. Advanced Materials. 2024;36(31). doi:10.1002/adma.202404107
BibTeX
@article{Lochenie2024,
author = {Lochenie, Charles and Duncan, Sheelagh and Zhou, Yanzi and Fingerhut, Leonie and Kiang, Alex and Benson, Sam and Jiang, Guanyu and Liu, Xiaogang and Mills, Bethany and Vendrell, Marc},
title = {Photosensitizer‐Amplified Antimicrobial Materials for Broad‐Spectrum Ablation of Resistant Pathogens in Ocular Infections},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {31},
doi = {10.1002/adma.202404107}
}
EUVIMED